Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study (Q29619653)
Jump to navigation
Jump to search
scientific article (publication date: November 2010)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study |
scientific article (publication date: November 2010) |
Statements
Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study (English)
2 references
Jacek Jassem
Mark Rother
Mario Barugel
Maria Błasińska-Morawiec
Jean-Yves Douillard
James Cassidy
Ronald Burkes
Yves Humblet
Fernando Rivera
Ilona Kocákova
Paul Ruff
Jean-Luc Canon
Kelly S Oliner
Michael Wolf
Jennifer Gansert
4 October 2010
2 references
28
2 references
31
2 references
Identifiers
3 references
3 references